Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diroximel Fumarate for Glutathione in Schizophrenia
NCT06957808Recruiting
- Sponsor
- King's College London
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in schizophrenia comparing DRF -> DRF with DRF -> Placebo (2 arms). Primary endpoint: Magnetic Resonance Spectroscopy glutathione levels in Anterior Cingulate Cortex at 4 weeks. Started Jan 2025; status: recruiting.
02
Drugs
diroximel fumarate
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT06957808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06957808.